Your browser doesn't support javascript.
loading
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.
Temple, William C; Nix, Matthew A; Naik, Akul; Izgutdina, Adila; Huang, Benjamin J; Wicaksono, Gianina; Phojanakong, Paul; Serrano, Juan Antonio Camara; Young, Elizabeth P; Ramos, Emilio; Salangsang, Fernando; Steri, Veronica; Xirenayi, Simayijiang; Hermiston, Michelle; Logan, Aaron C; Stieglitz, Elliot; Wiita, Arun P.
Afiliação
  • Temple WC; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Nix MA; Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Naik A; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Izgutdina A; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Huang BJ; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Wicaksono G; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Phojanakong P; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Serrano JAC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Young EP; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Ramos E; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Salangsang F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Steri V; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Xirenayi S; Department of Laboratory Medicine, University of California, San Francisco, California, USA.
  • Hermiston M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Logan AC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
  • Stieglitz E; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
  • Wiita AP; Department of Pediatrics, Division of Hematology/Oncology, University of California, UCSF Benioff Children's Hospital, San Francisco, California, USA.
J Immunother Cancer ; 11(11)2023 11 24.
Article em En | MEDLINE | ID: mdl-38007238
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camelídeos Americanos / Linfoma de Burkitt / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camelídeos Americanos / Linfoma de Burkitt / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos